These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8575214)

  • 21. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
    Rampalli AM; Gao CY; Chauthaiwale VM; Zelenka PS
    Oncogene; 1998 Jan; 16(3):399-408. PubMed ID: 9467965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry.
    Moberg K; Starz MA; Lees JA
    Mol Cell Biol; 1996 Apr; 16(4):1436-49. PubMed ID: 8657117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposite functions for E2F1 and E2F4 in human epidermal keratinocyte differentiation.
    Paramio JM; Segrelles C; Casanova ML; Jorcano JL
    J Biol Chem; 2000 Dec; 275(52):41219-26. PubMed ID: 11005809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of an E2F-p130 complex formed during growth arrest.
    Corbeil HB; Branton PE
    Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells.
    Tsuboi N; Yoshida H; Kawamura T; Furukawa Y; Hosoya T; Yamada H
    Kidney Int; 2000 Apr; 57(4):1581-9. PubMed ID: 10760093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
    Ahmad N; Gupta S; Mukhtar H
    Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression patterns of retinoblastoma and E2F family proteins during corneal development.
    Francesconi CM; Hutcheon AE; Chung EH; Dalbone AC; Joyce NC; Zieske JD
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1054-62. PubMed ID: 10752941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control.
    Classon M; Salama S; Gorka C; Mulloy R; Braun P; Harlow E
    Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10820-5. PubMed ID: 10995475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of E2F transcription factors by p53 tumor suppressor protein.
    Vaishnav YN; Pant V
    DNA Cell Biol; 1999 Dec; 18(12):911-22. PubMed ID: 10619603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
    Ferreira R; Magnaghi-Jaulin L; Robin P; Harel-Bellan A; Trouche D
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10493-8. PubMed ID: 9724731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis.
    Hiebert SW; Packham G; Strom DK; Haffner R; Oren M; Zambetti G; Cleveland JL
    Mol Cell Biol; 1995 Dec; 15(12):6864-74. PubMed ID: 8524253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional roles of E2F in cell cycle regulation.
    Fan J; Bertino JR
    Oncogene; 1997 Mar; 14(10):1191-200. PubMed ID: 9121768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
    Alevizopoulos K; Sanchez B; Amati B
    Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays.
    Inman GJ; Farrell PJ
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2141-9. PubMed ID: 7561751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
    Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
    Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.
    Wang D; Russell JL; Johnson DG
    Mol Cell Biol; 2000 May; 20(10):3417-24. PubMed ID: 10779331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential activities of E2F family members: unique functions in regulating transcription.
    Pierce AM; Schneider-Broussard R; Philhower JL; Johnson DG
    Mol Carcinog; 1998 Jul; 22(3):190-8. PubMed ID: 9688145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of E2F-4/DP-1-stimulated transcription by p202.
    Choubey D; Gutterman JU
    Oncogene; 1997 Jul; 15(3):291-301. PubMed ID: 9233764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.